CL2011001017A1 - Composicion farmaceutica acuosa que no provoca ardor ni irritacion, que comprende un ingrediente anestesico de accion topica, un alcanol inferior, un agente reforzador de la penetracion molecular y un portador; su uso para aliviar el dolor asociado con herpes zoster. - Google Patents
Composicion farmaceutica acuosa que no provoca ardor ni irritacion, que comprende un ingrediente anestesico de accion topica, un alcanol inferior, un agente reforzador de la penetracion molecular y un portador; su uso para aliviar el dolor asociado con herpes zoster.Info
- Publication number
- CL2011001017A1 CL2011001017A1 CL2011001017A CL2011001017A CL2011001017A1 CL 2011001017 A1 CL2011001017 A1 CL 2011001017A1 CL 2011001017 A CL2011001017 A CL 2011001017A CL 2011001017 A CL2011001017 A CL 2011001017A CL 2011001017 A1 CL2011001017 A1 CL 2011001017A1
- Authority
- CL
- Chile
- Prior art keywords
- irritation
- carrier
- pharmaceutical composition
- reinforcing agent
- pain associated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Composición farmacéutica acuosa que no provoca ardor ni irritación, que comprende un ingrediente anestésico de acción tópica, un alcanol inferior, un agente reforzador de la penetración molecular y un portador; su uso para aliviar el dolor asociado con herpes zóster.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11212308P | 2008-11-06 | 2008-11-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2011001017A1 true CL2011001017A1 (es) | 2011-09-30 |
Family
ID=41508318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2011001017A CL2011001017A1 (es) | 2008-11-06 | 2011-05-05 | Composicion farmaceutica acuosa que no provoca ardor ni irritacion, que comprende un ingrediente anestesico de accion topica, un alcanol inferior, un agente reforzador de la penetracion molecular y un portador; su uso para aliviar el dolor asociado con herpes zoster. |
Country Status (6)
Country | Link |
---|---|
US (1) | US20110288123A1 (es) |
EP (1) | EP2349337A1 (es) |
BR (1) | BRPI0921604A2 (es) |
CA (1) | CA2742603A1 (es) |
CL (1) | CL2011001017A1 (es) |
WO (1) | WO2010054093A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007033180A1 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds |
WO2007033082A2 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Compositions comprising dimethyl sulfoxide (dmso) |
US7955418B2 (en) | 2005-09-12 | 2011-06-07 | Abela Pharmaceuticals, Inc. | Systems for removing dimethyl sulfoxide (DMSO) or related compounds or odors associated with same |
US20120214874A1 (en) | 2009-08-26 | 2012-08-23 | Nuvo Research Inc. | Pharmaceutical formulations and methods of use |
KR20120093993A (ko) | 2009-10-30 | 2012-08-23 | 아벨라 파마슈티칼스, 인코포레이티드 | 퇴행성 관절염 치료를 위한 디메틸설폭사이드 및 메틸설포닐메탄 제제 |
US8846725B2 (en) * | 2011-01-24 | 2014-09-30 | Quadex Pharmaceuticals, Llc | Highly penetrating compositions and methods for treating pathogen-induced disordered tissues |
US9144553B2 (en) | 2012-12-21 | 2015-09-29 | Teikoku Pharma Usa, Inc. | Compositions and methods for transdermal delivery of hormones and other medicinal agents |
GB201305622D0 (en) * | 2013-03-27 | 2013-05-15 | Sas Ltd | Composition |
US20150141515A1 (en) * | 2013-11-20 | 2015-05-21 | Firstline Meds, Inc. | Compositions and methods for delivery of nsaid and anesthetic |
US10039830B2 (en) * | 2016-03-04 | 2018-08-07 | Cetylite Industries, Inc. | Topical anesthetic composition |
RU2634264C1 (ru) * | 2016-09-19 | 2017-10-24 | Александр Ливиевич Ураков | Крем-молочко для лечения опоясывающего лишая |
US11951082B2 (en) * | 2022-08-22 | 2024-04-09 | Ford Therapeutics, Llc | Composition of chlorhexidine |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1617282A1 (de) * | 1965-11-30 | 1975-02-06 | Astra Pharma Prod | Vorrichtung zur lokalanaesthetisierung durch oertliche aufbringung und verfahren zur herstellung dieser vorrichtung |
US5411738A (en) * | 1989-03-17 | 1995-05-02 | Hind Health Care, Inc. | Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine |
JP3115625B2 (ja) * | 1991-03-30 | 2000-12-11 | 帝國製薬株式会社 | リドカイン含有外用貼付剤 |
CA2446060A1 (en) * | 2001-05-07 | 2002-11-14 | Corium International | Compositions and delivery systems for administration of a local anesthetic agent |
WO2008088756A1 (en) * | 2007-01-12 | 2008-07-24 | Bridge Pharma, Inc. | Dermal compositions of substituted amides and the use thereof as medication for pain and pruritus |
-
2009
- 2009-11-05 WO PCT/US2009/063414 patent/WO2010054093A1/en active Application Filing
- 2009-11-05 CA CA2742603A patent/CA2742603A1/en not_active Abandoned
- 2009-11-05 EP EP09748923A patent/EP2349337A1/en not_active Withdrawn
- 2009-11-05 US US13/127,470 patent/US20110288123A1/en not_active Abandoned
- 2009-11-05 BR BRPI0921604A patent/BRPI0921604A2/pt not_active Application Discontinuation
-
2011
- 2011-05-05 CL CL2011001017A patent/CL2011001017A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2010054093A1 (en) | 2010-05-14 |
US20110288123A1 (en) | 2011-11-24 |
BRPI0921604A2 (pt) | 2015-12-29 |
CA2742603A1 (en) | 2010-05-14 |
EP2349337A1 (en) | 2011-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2011001017A1 (es) | Composicion farmaceutica acuosa que no provoca ardor ni irritacion, que comprende un ingrediente anestesico de accion topica, un alcanol inferior, un agente reforzador de la penetracion molecular y un portador; su uso para aliviar el dolor asociado con herpes zoster. | |
BRPI0510842A (pt) | composição e seu uso | |
CL2008000442A1 (es) | Composicion farmaceutica que comprende a un quitosano, un ingrediente activo cosmetico o farmaceutico, y un solvente volatil; y su uso para tratar psoriasis, micosis entre otras enfermedades. | |
MX2011011514A (es) | Formulaciones de canabidiol y metodos para utilizarlas. | |
CO6470850A2 (es) | Composición antimicrobiana humectante | |
CL2008001268A1 (es) | Compuestos derivados de n-[6-amino-5-aril-piridin-2-il]-carboxamida; composicion farmaceutica que los comprende; composicion farmaceutica combinada que los comprende junto a otro agente farmacologico adicional; y uso de los mismos en el tratamiento del dolor. | |
BR112012010083B8 (pt) | Composição farmacêutica tópica de liberação sustentada e uso relacionado | |
AR062622A1 (es) | Formulaciones topicas para administracion local que contienen indoxacarb | |
BRPI0514474A (pt) | multiparticulados | |
UY28662A1 (es) | Agente endoparasiticida para administracion topica | |
CL2008002319A1 (es) | Compuestos derivados de pirrolopirimidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer. | |
GT201000008A (es) | Agentes citotoxicos que comprenden nuevos derivados de tomaimicina y su uso terapeutico | |
CL2013002550A1 (es) | Una formulacion farmaceutica inyectable subcutanea liquida estable altamente concentrada de un anticuerpo anti-her2 farmaceuticamente activo que consiste esencialmente de trastuzumab; his/hci un agente estabilizador y un surfactante no ionico; kit y su uso para tratar enfermedades tales como cancer (divisional de solicitud n°0269-2012). | |
BRPI0511389A (pt) | composição e seu uso | |
BRPI0921063B8 (pt) | composto, e, composição agonística para receptor de melanocortina | |
CL2011002315A1 (es) | Compuestos derivados de pirimidindiona fusionados con pirrol, moduladores de receptores trpa1; composicion farmaceutica; y uso para tratar el dolor cronico, dolor reumatoide artritico o dolor osteoartritico. | |
CL2008000188A1 (es) | Agente para suprimir la reaccion de rechazo cronica que comprende como ingrediente activo un inhibidor de il-6; y uso del inhibidor de il-6. | |
AR054581A1 (es) | Composiciones farmaceuticas que comprenden levetiracetam y proceso para su preparacion | |
BR112015018087A8 (pt) | composto, composição farmacêutica e uso | |
PE20140936A1 (es) | Composiciones transdermicas de ibuprofeno y metodos de uso de las mismas | |
BR112014016661A2 (pt) | formulação de liberação prolongada para reduzir a frequência de urinação e método de uso da mesma | |
PE20150773A1 (es) | Composiciones farmaceuticas para la liberacion sostenida de fenilefrina | |
BR112014016550A8 (pt) | formulação de liberação retardada para reduzir a frequência de urinação e método de uso da mesma | |
BRPI0912112B8 (pt) | composição farmacêutica compreendendo composto tendo atividade antagonística em receptor de adenosina a2a útil em suprimir tolerância analgésica | |
CL2011000268A1 (es) | Uso de dronedarona para preparar un medicamento util en la prevencion del ictus o ataque isquemico transitorio. |